Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

SHSE:600613 주식 보고서

시가총액: CN¥2.7b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Shanghai Shenqi Pharmaceutical Investment Management 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Feng Bin

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기13.1yrs
CEO 소유권n/a
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

Recent updates

Why Shanghai Shenqi Pharmaceutical Investment Management's (SHSE:600613) Earnings Are Better Than They Seem

May 06
Why Shanghai Shenqi Pharmaceutical Investment Management's (SHSE:600613) Earnings Are Better Than They Seem

Investor Optimism Abounds Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE:600613) But Growth Is Lacking

Apr 17
Investor Optimism Abounds Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE:600613) But Growth Is Lacking

CEO

Feng Bin (50 yo)

13.1yrs

테뉴어

CN¥451,700

보상

Mr. Feng Bin is the Managing Director and Director of Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. (formerly known as Shanghai Wingsung Investment Management Co., Ltd.) and served as its...